A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis

NCT02401191 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
105
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi